Roberto Trelles‐Martínez

ORCID: 0000-0001-9410-9717
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Digital Imaging for Blood Diseases
  • AI in cancer detection
  • Platelet Disorders and Treatments
  • Single-cell and spatial transcriptomics
  • COVID-19 Clinical Research Studies
  • Artificial Intelligence in Healthcare
  • Blood properties and coagulation
  • Hematological disorders and diagnostics
  • Hemophilia Treatment and Research
  • SARS-CoV-2 and COVID-19 Research
  • Artificial Intelligence in Healthcare and Education
  • Hemostasis and retained surgical items
  • Immunodeficiency and Autoimmune Disorders
  • European and International Law Studies
  • Lymphoma Diagnosis and Treatment
  • Heparin-Induced Thrombocytopenia and Thrombosis
  • COVID-19 and healthcare impacts
  • Cell Image Analysis Techniques
  • Blood disorders and treatments
  • Blood groups and transfusion
  • Acute Myeloid Leukemia Research

Hospital Universitario Fundación Alcorcón
2021-2024

Hospital Universitario La Paz
2020-2021

Hospital Clínico San Carlos
2018

Abstract Analysis of bone marrow aspirates (BMAs) is an essential step in the diagnosis hematological disorders. This analysis usually performed based on a visual examination samples under conventional optical microscope, which involves labor-intensive process, limited by clinical experience and subject to high observer variability. In this work, we present comprehensive digital microscopy system that enables BMA for cell type counting differentiation efficient objective manner. not only...

10.1093/micmic/ozad143 article EN cc-by-nc Microscopy and Microanalysis 2024-02-01

Summary Thrombocytopenia has been identified as a common complication of severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) infection in the general population. In an attempt to determine impact coronavirus disease 2019 (COVID‐19) patients with immune thrombocytopenia (ITP), retrospective single‐centre study was performed. Thrombocytosis observed chronic ITP after SARS‐CoV‐2 infection, frequently needing treatment adjustment or even discontinuation therapy. Relapses and newly...

10.1111/bjh.17077 article EN British Journal of Haematology 2020-09-10

We present the first registry of patients with congenital bleeding disorders and COVID-19. The study has been carried out in Community Madrid, which highest number cases Spain. objective is to understand incidence COVID-19, course disease if it occurs psychosocial occupational impact on this population.We included 345 (246 haemophilia, 69 von Willebrand Disease, two rare 28 carriers haemophilia). A telephone survey was used collect data.Forty-two presented symptoms suggestive infection by...

10.1111/hae.14089 article EN Haemophilia 2020-06-11

<b><i>Introduction:</i></b> There is no consensus on the management of coronavirus disease (COVID-19) in patients with secondary immunosuppression due to either an underlying hematological or effects immunochemotherapy (ICT). Some them may present persistent infection multiple relapses COVID-19, requiring several admissions. This study evaluated clinical characteristics and outcomes after treatment 5 follicular lymphoma (FL), previously treated ICT, who developed...

10.1159/000521121 article EN other-oa Acta Haematologica 2021-11-26

The main clinical manifestations of hemophilia are muscle and joint bleeding. Recurrent bleeding leads to a degenerative process known as hemophilic arthropathy. development inhibitors (antibodies against FVIII/FIX concentrates) is the complication in treatment hemophilia. objective was assess safety efficacy manual therapy patient with inhibitor. A 26-year-old B inhibitor received physiotherapy based on for 3 months, frequency 2 sessions per week. status evaluated using Hemophilia Joint...

10.1186/s12891-018-1934-9 article EN cc-by BMC Musculoskeletal Disorders 2018-01-22

Artificial intelligence, particularly the growth of neural network research and development, has become an invaluable tool for data analysis, offering unrivalled solutions image generation, natural language processing, personalised suggestions. In meantime, biomedicine been presented as one pressing challenges 21st century. The inversion age pyramid, increase in longevity, negative environment due to pollution bad habits population have led a necessity methodologies that can help mitigate...

10.1016/j.heliyon.2023.e15940 article EN cc-by-nc-nd Heliyon 2023-05-01

Background and Objectives: The aim of this study was to determine the impact COVID-19 pandemic on lives patients with immune thrombocytopaenia (ITP) treated at our hospital. Materials Methods: conducted in Community Madrid, which has highest number cases Spain. We included 143 adult ITP (130 chronic ITP, 8 persistent 5 newly diagnosed ITP). a telephone survey collect data created registry. Overall, 24 presented symptoms suggestive COVID-19, confirmed by RT-PCR cases. cumulative incidence...

10.3390/medicina57030219 article EN cc-by Medicina 2021-03-01

Abstract Analysis of bone marrow aspirates (BMA) is an essential step in the diagnosis hematological disorders. This analysis usually performed based on visual examination samples under a conventional optical microscope, which involves labor-intensive process, limited by clinical experience and subject to high observer variability. In this work, we present comprehensive digital system that enables BMA for cell type counting differentiation efficient objective manner. not only provides...

10.1101/2022.08.30.22279373 preprint EN cc-by-nc-nd medRxiv (Cold Spring Harbor Laboratory) 2022-08-30

Background: Microscopic examination of bone marrow aspirates (BMA) is still, in almost every organization world-wide, a task that performed with conventional microscopes relying on an in-person diagnostic process. Being these samples left outside the digital world, it not possible to leverage tools such as Artificial Intelligence (AI) algorithms support diagnosis hematological medical images. Concerning BMA analysis, differential cell count (DCC) remains non-automated, being tedious and time...

10.1097/01.hs9.0000849784.81196.96 article EN cc-by-nc-nd HemaSphere 2022-06-01
Coming Soon ...